Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05105087 · ClinicalTrials.gov registry record · Early Phase 1
Gynecological Sentinel Lymph Nodes CEUS
A Early Phase 1 study, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 9
- Enrollment target
NCT05105087 is a Early Phase 1 study that has completed, run by Thomas Jefferson University. The registered enrollment target is 9 participants.
The verdict
NCT05105087, a Early Phase 1 study, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
This clinical trial compares the use of ultrasound for the detection of sentinel lymph nodes (SLNs) to the standard of care (which varies depending on cancer treatment). The ultrasound contrast agent is called Sonazoid and it consists of tiny gas-filled bubbles about the side of red blood cells. Diagnostic procedures, such as ultrasound with Sonazoid, may help identify more SLNs than standard of care in patients with cervical, vaginal, or vulvar cancer.
Interventions
- PROCEDURE Contrast-Enhanced Ultrasound
- DRUG Perflubutane Microbubble
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2022-04-28 |
| Est. Completion | 2025-01-29 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05105087
The ClinicalTrials.gov registry entry for NCT05105087 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Contrast-Enhanced Ultrasound is the first listed.
NCT05105087 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05105087 about?
NCT05105087 is a clinical study titled "Gynecological Sentinel Lymph Nodes CEUS". This clinical trial compares the use of ultrasound for the detection of sentinel lymph nodes (SLNs) to the standard of care (which varies depending on cancer treatment). The ultrasound contrast agent is called Sonazoid and it consists of tiny gas-filled bubbles about the side of red blood cells. Dia...
What is the current status of trial NCT05105087?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 9 participants. The study started on 2022-04-28. Estimated completion is 2025-01-29.
What interventions are being tested in trial NCT05105087?
The interventions under investigation include: Contrast-Enhanced Ultrasound (PROCEDURE), Perflubutane Microbubble (DRUG).
Who is sponsoring clinical trial NCT05105087?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.